{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:00:18Z","timestamp":1781254818096,"version":"3.54.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.exer.2025.110763","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:54:37Z","timestamp":1763654077000},"page":"110763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of CysLTR1 inhibition on cells of the retinal neurovascular unit in 5xFAD Alzheimer mice"],"prefix":"10.1016","volume":"262","author":[{"given":"Daniela","family":"Mayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Preishuber-Pfl\u00fcgl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Migschitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Amschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hitzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert A.","family":"Reitsamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-6830","authenticated-orcid":false,"given":"Andrea","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110763_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2018.05.002","article-title":"Characterization of impaired cerebrovascular structure in APP\/PS1 mouse brains","volume":"385","author":"Ahn","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2025.110763_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-201195","article-title":"Retinal ganglion cells functional changes in a mouse model of Alzheimer's disease are linked with neurotransmitter alterations","volume":"82","author":"Araya-Arriagada","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.exer.2025.110763_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197290","article-title":"Retinal degeneration and Alzheimer's disease: an evolving link","volume":"21","author":"Ashok","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.65.13.15","article-title":"Cysteine leukotriene receptor antagonist-montelukast effects on diabetic retinal microvascular endothelial cells curtail autophagy","volume":"65","author":"Awad","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1096\/fj.11-195792","article-title":"The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy","volume":"26","author":"Barajas-Espinosa","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2025.110763_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.exer.2025.110763_bib7","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","article-title":"Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease","volume":"115","author":"Bennett","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2025.110763_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/02699050902926317","article-title":"Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury","volume":"23","author":"Biber","year":"2009","journal-title":"Brain Inj."},{"key":"10.1016\/j.exer.2025.110763_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00011-017-1022-x","article-title":"Effects of COX1-2\/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice","volume":"66","author":"Bitto","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.exer.2025.110763_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109517","article-title":"Distribution of the cysteinyl leukotriene system components in the human, rat and mouse eye","volume":"232","author":"Brunner","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110763_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcell.2016.00103","article-title":"Evaluation of cysteinyl leukotriene signaling as a therapeutic target for colorectal cancer","volume":"4","author":"Burke","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.exer.2025.110763_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4481","article-title":"Mapping of microvascular architecture in the brain of an Alzheimer's disease mouse model using MRI","volume":"34","author":"Chang","year":"2021","journal-title":"NMR Biomed."},{"key":"10.1016\/j.exer.2025.110763_bib13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbi.2020.03.022","article-title":"5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease","volume":"88","author":"Chen","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.exer.2025.110763_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-024-01423-w","article-title":"Amyloid beta oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction","volume":"16","author":"Chen","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.exer.2025.110763_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084287","article-title":"Tools and biomarkers for the Study of retinal ganglion cell degeneration","volume":"23","author":"Corral-Domenge","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2018.03.017","article-title":"The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model","volume":"67","author":"Criscuolo","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.exer.2025.110763_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.4564","article-title":"A fluoro-Nissl dye identifies pericytes as distinct vascular mural cells during in vivo brain imaging","volume":"20","author":"Damisah","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1073\/pnas.1817325115","article-title":"Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis","volume":"116","author":"Duah","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2025.110763_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.exer.2025.110763_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102019","article-title":"The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice","volume":"89","author":"Forny Germano","year":"2024","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.exer.2025.110763_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101273","article-title":"Alzheimer's disease pathophysiology in the Retina","volume":"101","author":"Gaire","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2025.110763_bib22","first-page":"734","article-title":"[Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer's Disease Pathogenesis]","volume":"55","author":"Garbuz","year":"2021","journal-title":"Mol. Biol. (Mosc.)"},{"key":"10.1016\/j.exer.2025.110763_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","article-title":"Cerebrovascular pathology during the progression of experimental Alzheimer's disease","volume":"88","author":"Giannoni","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2025.110763_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer's Disease: a prelude to the pathological process or a consequence of it?","volume":"8","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2025.110763_bib25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fnins.2019.00925","article-title":"Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer's Disease patients, possible biomarkers for early diagnosis","volume":"13","author":"Grimaldi","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cub.2024.11.023","article-title":"Layer-specific anatomical and physiological features of the retina's neurovascular unit","volume":"35","author":"Grimes","year":"2025","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exer.2025.110763_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"5","key":"10.1016\/j.exer.2025.110763_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2025.110763_bib29","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.3233\/JAD-221064","article-title":"Microglia-mediated neurovascular unit dysfunction in Alzheimer's disease","volume":"94","author":"Huang","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.exer.2025.110763_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","article-title":"Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease","volume":"56","author":"Ikonomovic","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.exer.2025.110763_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814092","article-title":"The expression of major facilitator superfamily domain-containing Protein2a (Mfsd2a) and aquaporin 4 is altered in the retinas of a 5xFAD mouse model of Alzheimer's Disease","volume":"24","author":"Jovanovic Macura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1220036","article-title":"Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer's disease","volume":"15","author":"Jullienne","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib33","doi-asserted-by":"crossref","DOI":"10.1117\/1.NPh.8.3.035002","article-title":"Concurrent OCT and OCT angiography of retinal neurovascular degeneration in the 5XFAD Alzheimer's disease mice","volume":"8","author":"Kim","year":"2021","journal-title":"Neurophotonics"},{"issue":"2","key":"10.1016\/j.exer.2025.110763_bib34","first-page":"308","article-title":"Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic activity in aged mice","volume":"17","author":"Koller","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.exer.2025.110763_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","article-title":"Retinal pathological features and proteome signatures of Alzheimer's disease","volume":"145","author":"Koronyo","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.exer.2025.110763_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jnc.15565","article-title":"Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer's disease","volume":"164","author":"Kumar","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2025.110763_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neuropharm.2014.01.011","article-title":"Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Abeta1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice","volume":"79","author":"Lai","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.exer.2025.110763_bib38","article-title":"Modulating neuroinflammation as a prospective therapeutic target in Alzheimer's Disease","volume":"14","author":"Lee","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.exer.2025.110763_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer's disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.exer.2025.110763_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","article-title":"Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction","volume":"277","author":"Lenz","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2025.110763_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106114","article-title":"Dissecting the neurovascular unit in physiology and Alzheimer's disease: functions, imaging tools and genetic mouse models","volume":"181","author":"Li","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2025.110763_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081215","article-title":"Retinal dysfunction in Alzheimer's Disease and implications for biomarkers","volume":"11","author":"Liao","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2025.110763_bib43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib44","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"Marschallinger","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2025.110763_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152413","article-title":"Retinal vascular physiology biomarkers in a 5XFAD mouse model of Alzheimer's disease","volume":"11","author":"Matei","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.exer.2025.110763_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319397","article-title":"Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease","volume":"20","author":"McCool","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2025.110763_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1201982","article-title":"Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials","volume":"15","author":"Miao","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","article-title":"Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer's disease mice","volume":"8","author":"Michael","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.exer.2025.110763_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052782","article-title":"The leukotriene receptor antagonist montelukast attenuates neuroinflammation and affects cognition in transgenic 5xFAD mice","volume":"22","author":"Michael","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137320","article-title":"I2-Imidazoline ligand CR4056 improves memory, increases ApoE expression and reduces BBB leakage in 5xFAD mice","volume":"23","author":"Mota","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-031-64839-7_14","article-title":"Astrocyte-Neuron interactions in Alzheimer's disease","volume":"39","author":"Munoz-Castro","year":"2024","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.exer.2025.110763_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77501-8","article-title":"Microvessel isolation protocol for RNA visualization and profiling","volume":"14","author":"Naranjo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110763_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12987-024-00531-x","article-title":"Cognitive decline, Abeta pathology, and blood-brain barrier function in aged 5xFAD mice","volume":"21","author":"Nehra","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.exer.2025.110763_bib54","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0195","article-title":"Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters","volume":"370","author":"Newman","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib55","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112940","article-title":"Unveiling the role of astrogliosis in Alzheimer's disease pathology: insights into mechanisms and therapeutic approaches","volume":"141","author":"Paidlewar","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.exer.2025.110763_bib57","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/glia.24514","article-title":"ER-stress response in retinal Muller glia occurs significantly earlier than amyloid pathology in the Alzheimer's mouse brain and retina","volume":"72","author":"Palko","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.exer.2025.110763_bib58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2018.10.040","article-title":"A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease","volume":"842","author":"Rahman","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2025.110763_bib59","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1074\/jbc.M115.710665","article-title":"Phenotype-based discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a novel regulator of ocular angiogenesis","volume":"291","author":"Reynolds","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2025.110763_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-10-1","article-title":"Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level","volume":"10","author":"Sadleir","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.exer.2025.110763_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/intimm\/dxz044","article-title":"The leukotriene receptors as therapeutic targets of inflammatory diseases","volume":"31","author":"Sasaki","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.exer.2025.110763_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12728","article-title":"Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro","volume":"17","author":"Schultz","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.exer.2025.110763_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.exer.2025.110763_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","article-title":"Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index","volume":"362","author":"Sery","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.731614","article-title":"Retinal vasculopathy in Alzheimer's Disease","volume":"15","author":"Shi","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","article-title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina","volume":"139","author":"Shi","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.exer.2025.110763_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176755","article-title":"Neuromodulatory effects of leukotriene receptor antagonists: a comprehensive review","volume":"978","author":"Sood","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2025.110763_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042022","article-title":"The neurovascular unit dysfunction in Alzheimer's disease","volume":"22","author":"Soto-Rojas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110763_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70123","article-title":"Lycium barbarum extract enhanced neuroplasticity and functional recovery in 5xFAD mice via modulating microglial status of the central nervous system","volume":"30","author":"Sun","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.exer.2025.110763_bib70","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib71","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/0271678X21992462","article-title":"Cerebrovascular phenotypes in mouse models of Alzheimer's disease","volume":"41","author":"Szu","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.exer.2025.110763_bib72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10571-021-01126-y","article-title":"Decreased glucose metabolism and glutamine synthesis in the retina of a transgenic mouse model of Alzheimer's disease","volume":"42","author":"Tams","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.exer.2025.110763_bib73","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2021.07.015","article-title":"Vascular endothelial growth factor associated dissimilar cerebrovascular phenotypes in two different mouse models of Alzheimer's disease","volume":"107","author":"Tataryn","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exer.2025.110763_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108806","article-title":"Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension","volume":"213","author":"Trost","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110763_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer's disease","volume":"12","author":"Valiukas","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.exer.2025.110763_bib76","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2025.110763_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1227493","article-title":"Cooperation between neurovascular dysfunction and Abeta in Alzheimer's disease","volume":"16","author":"Wang","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.12.013","article-title":"Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases","volume":"87","author":"Wang","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exer.2025.110763_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101294","article-title":"Comprehensive analysis of the 5xFAD mouse model of Alzheimer's Disease using dMRI, immunohistochemistry, and neuronal and glial functional metabolic mapping","volume":"14","author":"Westi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2025.110763_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bpa.12152","article-title":"The pericyte: a forgotten cell type with important implications for Alzheimer's disease?","volume":"24","author":"Winkler","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.exer.2025.110763_bib81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13195-021-00892-7","article-title":"Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia","volume":"13","author":"Xiong","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.exer.2025.110763_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"Muller cell degeneration and microglial dysfunction in the Alzheimer's retina","volume":"10","author":"Xu","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.exer.2025.110763_bib83","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/0118715273258337230925040049","article-title":"Montelukast ameliorates scopolamine-induced Alzheimer's Disease: role on cholinergic neurotransmission, antioxidant defence System, neuroinflammation and expression of BDNF","volume":"23","author":"Yerraguravagari","year":"2024","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.exer.2025.110763_bib84","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnins.2020.00334","article-title":"Neurovascular unit dysfunction and neurodegenerative disorders","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib85","article-title":"Brain and retinal abnormalities in the 5xFAD mouse model of Alzheimer's Disease at early stages","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110763_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1089005","article-title":"Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer's disease","volume":"15","author":"Zhukov","year":"2023","journal-title":"Front. Aging Neurosci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525005366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525005366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:41:24Z","timestamp":1781253684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525005366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":86,"alternative-id":["S0014483525005366"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110763","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of CysLTR1 inhibition on cells of the retinal neurovascular unit in 5xFAD Alzheimer mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110763"}}